-
1
-
-
84870469320
-
-
American Psychiatric Association Washington, DC American Psychiatric Association, 4th ed., Text Revision
-
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision. Washington, DC: American Psychiatric Association; 2000.
-
(2000)
Diagnostic and Statistical Manual of Mental Disorders
-
-
-
2
-
-
14844334624
-
Remission in schizophrenia: Proposed criteria and rationale for consensus
-
Andreasen NC, Carpenter Jr. WT, Kane JM, Lasser RA, Marder SR, Weinberger DR: Remission in schizophrenia: Proposed criteria and rationale for consensus. Am J Psychiatry 162:441-449, 2005.
-
(2005)
Am J Psychiatry
, vol.162
, pp. 441-449
-
-
Andreasen, N.C.1
Carpenter Jr., W.T.2
Kane, J.M.3
Lasser, R.A.4
Marder, S.R.5
Weinberger, D.R.6
-
3
-
-
12944295044
-
Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia
-
Ascher-Svanum H, Stensland M, Zhao Z, Kinon BJ: Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia. BMC Psychiatry 5:3, 2005a.
-
(2005)
BMC Psychiatry
, vol.5
, Issue.3
-
-
Ascher-Svanum, H.1
Stensland, M.2
Zhao, Z.3
Kinon, B.J.4
-
4
-
-
33645471530
-
Weight gain as a prognostic indicator of therapeutic improvement during acute treatment of schizophrenia with placebo or active antipsychotic
-
Ascher-Svanum H, Stensland M, Zhao Z, Kinon BJ: Weight gain as a prognostic indicator of therapeutic improvement during acute treatment of schizophrenia with placebo or active antipsychotic. J Psychopharmacol 19 Suppl 6:110-117, 2005b.
-
(2005)
J Psychopharmacol
, vol.19
, Issue.SUPPL. 6
, pp. 110-117
-
-
Ascher-Svanum, H.1
Stensland, M.2
Zhao, Z.3
Kinon, B.J.4
-
5
-
-
33746886660
-
Association of initial antipsychotic response to clozapine and long-term weight gain
-
Bai YM, Lin CC, Chen JY, Lin CY, Su TP, Chou P: Association of initial antipsychotic response to clozapine and long-term weight gain. Am J Psychiatry 163:1276-1279, 2006.
-
(2006)
Am J Psychiatry
, vol.163
, pp. 1276-1279
-
-
Bai, Y.M.1
Lin, C.C.2
Chen, J.Y.3
Lin, C.Y.4
Su, T.P.5
Chou, P.6
-
6
-
-
0035024729
-
Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, Haloperidol, or risperidone
-
Basson BR, Kinon BJ, Taylor CC, Szymanski KA, Gilmore JA, Tollefson GD: Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone. J Clin Psychiatry 62:231-238, 2001.
-
(2001)
J Clin Psychiatry
, vol.62
, pp. 231-238
-
-
Basson, B.R.1
Kinon, B.J.2
Taylor, C.C.3
Szymanski, K.A.4
Gilmore, J.A.5
Tollefson, G.D.6
-
7
-
-
0029904335
-
Differential effect of clozapine on weight: A controlled study
-
Bustillo JR, Buchanan RW, Irish D, Breier A: Differential effect of clozapine on weight: A controlled study. Am J Psychiatry 153:817-819, 1996.
-
(1996)
Am J Psychiatry
, vol.153
, pp. 817-819
-
-
Bustillo, J.R.1
Buchanan, R.W.2
Irish, D.3
Breier, A.4
-
8
-
-
46649109792
-
Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents
-
Correll CU: Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents. J Clin Psychiatry 69 Suppl 4:26-36, 2008.
-
(2008)
J Clin Psychiatry
, vol.69
, Issue.SUPPL. 4
, pp. 26-36
-
-
Correll, C.U.1
-
10
-
-
70350738289
-
Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents
-
Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK: Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA 302:1765-1773, 2009.
-
(2009)
JAMA
, vol.302
, pp. 1765-1773
-
-
Correll, C.U.1
Manu, P.2
Olshanskiy, V.3
Napolitano, B.4
Kane, J.M.5
Malhotra, A.K.6
-
11
-
-
0036115924
-
Antipsychoticinduced weight gain and therapeutic response: A differential association
-
Czobor P, Volavka J, Sheitman B, Lindenmayer JP, Citrome L, McEvoy J, Cooper TB, Chakos M, Lieberman JA: Antipsychoticinduced weight gain and therapeutic response: A differential association. J Clin Psychopharmacol 22:244-251, 2002.
-
(2002)
J Clin Psychopharmacol
, vol.22
, pp. 244-251
-
-
Czobor, P.1
Volavka, J.2
Sheitman, B.3
Lindenmayer, J.P.4
Citrome, L.5
McEvoy, J.6
Cooper, T.B.7
Chakos, M.8
Lieberman, J.A.9
-
12
-
-
84856466929
-
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
-
De Hert M, Detraux J, van Winkel R, Yu W, Correll CU: Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol 8:114-126, 2011.
-
(2011)
Nat Rev Endocrinol
, vol.8
, pp. 114-126
-
-
De Hert, M.1
Detraux, J.2
Van Winkel, R.3
Yu, W.4
Correll, C.U.5
-
13
-
-
26444447991
-
Metabolic syndrome in bipolar disorder: Findings from the Bipolar Disorder Center for Pennsylvanians
-
Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ: Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord 7:424-430, 2005.
-
(2005)
Bipolar Disord
, vol.7
, pp. 424-430
-
-
Fagiolini, A.1
Frank, E.2
Scott, J.A.3
Turkin, S.4
Kupfer, D.J.5
-
14
-
-
0037229426
-
Obesity as a correlate of outcome in patients with bipolar i disorder
-
Fagiolini A, Kupfer DJ, Houck PR, Novick DM, Frank E: Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry 160:112-117, 2003.
-
(2003)
Am J Psychiatry
, vol.160
, pp. 112-117
-
-
Fagiolini, A.1
Kupfer, D.J.2
Houck, P.R.3
Novick, D.M.4
Frank, E.5
-
15
-
-
84867811761
-
Efficacy and safety of quetiapine in adolescents with schizophrenia: A 6-week, double-blind, placebo-controlled trial
-
Findling RL, McKenna K, Earley WR, Stankowski J, Pathak S: Efficacy and safety of quetiapine in adolescents with schizophrenia: a 6-week, double-blind, placebo-controlled trial. J Child Adolesc Psychopharmacol 22:327-342, 2012.
-
(2012)
J Child Adolesc Psychopharmacol
, vol.22
, pp. 327-342
-
-
Findling, R.L.1
McKenna, K.2
Earley, W.R.3
Stankowski, J.4
Pathak, S.5
-
16
-
-
55749106241
-
A multiple-center, Randomized, Double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia
-
Findling RL, Robb A, Nyilas M, Forbes RA, Jin N, Ivanova S, Marcus R, McQuade RD, Iwamoto T, Carson WH: A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia. Am J Psychiatry 165:1432-1441, 2008.
-
(2008)
Am J Psychiatry
, vol.165
, pp. 1432-1441
-
-
Findling, R.L.1
Robb, A.2
Nyilas, M.3
Forbes, R.A.4
Jin, N.5
Ivanova, S.6
Marcus, R.7
McQuade, R.D.8
Iwamoto, T.9
Carson, W.H.10
-
18
-
-
34547650644
-
Treatment of early-onset schizophrenia spectrum disorders (TEOSS): Demographic and clinical characteristics
-
Frazier JA, McClellan J, Findling RL, Vitiello B, Anderson R, Zablotsky B, Williams E, McNamara NK, Jackson JA, Ritz L, Hlastala SA, Pierson L, Varley JA, Puglia M, Maloney AE, Ambler D, Hunt-Harrison T, Hamer RM, Noyes N, Lieberman JA, Sikich L: Treatment of early-onset schizophrenia spectrum disorders (TEOSS): Demographic and clinical characteristics. J Am Acad Child Adolesc Psychiatry 46:979-988, 2007.
-
(2007)
J Am Acad Child Adolesc Psychiatry
, vol.46
, pp. 979-988
-
-
Frazier, J.A.1
McClellan, J.2
Findling, R.L.3
Vitiello, B.4
Anderson, R.5
Zablotsky, B.6
Williams, E.7
McNamara, N.K.8
Jackson, J.A.9
Ritz, L.10
Hlastala, S.A.11
Pierson, L.12
Varley, J.A.13
Puglia, M.14
Maloney, A.E.15
Ambler, D.16
Hunt-Harrison, T.17
Hamer, R.M.18
Noyes, N.19
Lieberman, J.A.20
Sikich, L.21
more..
-
19
-
-
0027431875
-
Psychotic disorders diagnosed in adolescence. Outcome at age 30 years
-
Gillberg IC, Hellgren L, Gillberg C: Psychotic disorders diagnosed in adolescence. Outcome at age 30 years. J Child Psychol Psychiatry 34:1173-1185, 1993.
-
(1993)
J Child Psychol Psychiatry
, vol.34
, pp. 1173-1185
-
-
Gillberg, I.C.1
Hellgren, L.2
Gillberg, C.3
-
20
-
-
60349129918
-
Preliminary findings regarding overweight and obesity in pediatric bipolar disorder
-
Goldstein BI, Birmaher B, Axelson DA, Goldstein TR, Esposito-Smythers C, Strober MA, Hunt J, Leonard H, Gill MK, Iyengar S, Grimm C, Yang M, Ryan ND, Keller MB: Preliminary findings regarding overweight and obesity in pediatric bipolar disorder. J Clin Psychiatry 69:1953-1959, 2008.
-
(1953)
J Clin Psychiatry 69
, vol.2008
-
-
Goldstein, B.I.1
Birmaher, B.2
Axelson, D.A.3
Goldstein, T.R.4
Esposito-Smythers, C.5
Strober, M.A.6
Hunt, J.7
Leonard, H.8
Gill, M.K.9
Iyengar, S.10
Grimm, C.11
Yang, M.12
Ryan, N.D.13
Keller, M.B.14
-
21
-
-
70350546566
-
A 6-week, randomized, double-blind, placebocontrolled study of the efficacy and safety of risperidone in adolescents with schizophrenia
-
Haas M, Unis AS, Armenteros J, Copenhaver MD, Quiroz JA, Kushner SF: A 6-week, randomized, double-blind, placebocontrolled study of the efficacy and safety of risperidone in adolescents with schizophrenia. J Child Adolesc Psychopharmacol 19:611-621, 2009.
-
(2009)
J Child Adolesc Psychopharmacol
, vol.19
, pp. 611-621
-
-
Haas, M.1
Unis, A.S.2
Armenteros, J.3
Copenhaver, M.D.4
Quiroz, J.A.5
Kushner, S.F.6
-
22
-
-
13744257463
-
Weight gain during treatment of bipolar i patients with olanzapine
-
Hennen J, Perlis RH, Sachs G, Tohen M, Baldessarini RJ: Weight gain during treatment of bipolar I patients with olanzapine. J Clin Psychiatry 65:1679-1687, 2004.
-
(2004)
J Clin Psychiatry
, vol.65
, pp. 1679-1687
-
-
Hennen, J.1
Perlis, R.H.2
Sachs, G.3
Tohen, M.4
Baldessarini, R.J.5
-
23
-
-
79955480406
-
The association between weight change and symptom reduction in the CATIE schizophrenia trial
-
Hermes E, Nasrallah H, Davis V, Meyer J, McEvoy J, Goff D, Davis S, Stroup TS, Swartz M, Lieberman J, Rosenheck R: The association between weight change and symptom reduction in the CATIE schizophrenia trial. Schizophr Res 128:166-170, 2011.
-
(2011)
Schizophr Res
, vol.128
, pp. 166-170
-
-
Hermes, E.1
Nasrallah, H.2
Davis, V.3
Meyer, J.4
McEvoy, J.5
Goff, D.6
Davis, S.7
Stroup, T.S.8
Swartz, M.9
Lieberman, J.10
Rosenheck, R.11
-
24
-
-
0028835191
-
Weight gain induced by clozapine
-
Hummer M, Kemmler G, Kurtz M, Kurtzthaler I, Oberbauer H, Fleischhacker WW: Weight gain induced by clozapine. Eur Neuropsychopharmacol 5:437-440, 1995.
-
(1995)
Eur Neuropsychopharmacol
, vol.5
, pp. 437-440
-
-
Hummer, M.1
Kemmler, G.2
Kurtz, M.3
Kurtzthaler, I.4
Oberbauer, H.5
Fleischhacker, W.W.6
-
25
-
-
44049097402
-
Effectiveness of second generation antipsychotics: A systematic review of randomized trials
-
Johnsen E, Jrgensen HA: Effectiveness of second generation antipsychotics: A systematic review of randomized trials. BMC Psychiatry 8:31, 2008.
-
(2008)
BMC Psychiatry
, vol.8
, pp. 31
-
-
Johnsen, E.1
Jrgensen, H.A.2
-
26
-
-
0030954243
-
Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (k-sads-pl): Initial reliability and validity data
-
Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988, 1997.
-
(1997)
J Am Acad Child Adolesc Psychiatry
, vol.36
, pp. 980-988
-
-
Kaufman, J.1
Birmaher, B.2
Brent, D.3
Rao, U.4
Flynn, C.5
Moreci, P.6
Williamson, D.7
Ryan, N.8
-
27
-
-
0023606101
-
The positive and negative syndrome scale (PANSS) for schizophrenia
-
Kay SR, Fiszbein A, Opler LA: The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261-276, 1987.
-
(1987)
Schizophr Bull
, vol.13
, pp. 261-276
-
-
Kay, S.R.1
Fiszbein, A.2
Opler, L.A.3
-
28
-
-
0020629612
-
Initial anticholinergic prophylaxis for neuroleptic-induced extrapyramidal syndromes
-
Keepers GA, Clappison VJ, Casey DE: Initial anticholinergic prophylaxis for neuroleptic-induced extrapyramidal syndromes. Arch Gen Psychiatry 40:1113-1117, 1983.
-
(1983)
Arch Gen Psychiatry
, vol.40
, pp. 1113-1117
-
-
Keepers, G.A.1
Clappison, V.J.2
Casey, D.E.3
-
29
-
-
77954856854
-
Medical comorbidity in bipolar disorder: Relationship between illnesses of the endocrine/metabolic system and treatment outcome
-
Kemp DE, Gao K, Chan PK, Ganocy SJ, Findling RL, Calabrese JR: Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome. Bipolar Disord 12:404-413, 2010.
-
(2010)
Bipolar Disord
, vol.12
, pp. 404-413
-
-
Kemp, D.E.1
Gao, K.2
Chan, P.K.3
Ganocy, S.J.4
Findling, R.L.5
Calabrese, J.R.6
-
30
-
-
34548834176
-
Overweight and obesity affect treatment response in major depression
-
Kloiber S, Ising M, Reppermund S, Horstmann S, Dose T, Majer M, Zihl J, Pfister H, Unschuld PG, Holsboer F, Lucae S: Overweight and obesity affect treatment response in major depression. Biol Psychiatry 62:321-326, 2007.
-
(2007)
Biol Psychiatry
, vol.62
, pp. 321-326
-
-
Kloiber, S.1
Ising, M.2
Reppermund, S.3
Horstmann, S.4
Dose, T.5
Majer, M.6
Zihl, J.7
Pfister, H.8
Unschuld, P.G.9
Holsboer, F.10
Lucae, S.11
-
31
-
-
38449122349
-
Assessment of child and adolescent overweight and obesity
-
Krebs NF, Himes JH, Jacobson D, Nicklas TA, Guilday P, Styne D: Assessment of child and adolescent overweight and obesity. Pediatrics 120 Suppl 4:S193-228, 2007.
-
(2007)
Pediatrics
, vol.120 SUPPL
, Issue.4
-
-
Krebs, N.F.1
Himes, J.H.2
Jacobson, D.3
Nicklas, T.A.4
Guilday, P.5
Styne, D.6
-
32
-
-
0031722774
-
Open-label olanzapine treatment in five preadolescent children
-
Krishnamoorthy J, King BH: Open-label olanzapine treatment in five preadolescent children. J Child Adolesc Psychopharmacol 8:107-13, 1998.
-
(1998)
J Child Adolesc Psychopharmacol
, vol.8
, pp. 107-113
-
-
Krishnamoorthy, J.1
King, B.H.2
-
33
-
-
58249139362
-
Olanzapine versus placebo in adolescents with schizophrenia: A 6-week, randomized, double-blind, placebo-controlled trial
-
Kryzhanovskaya L, Schulz SC, McDougle C, Frazier J, Dittmann R, Robertson-Plouch C, Bauer T, Xu W, Wang W, Carlson J, Tohen M: Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 48:60-70, 2009a.
-
(2009)
J Am Acad Child Adolesc Psychiatry
, vol.48
, pp. 60-70
-
-
Kryzhanovskaya, L.1
Schulz, S.C.2
McDougle, C.3
Frazier, J.4
Dittmann, R.5
Robertson-Plouch, C.6
Bauer, T.7
Xu, W.8
Wang, W.9
Carlson, J.10
Tohen, M.11
-
34
-
-
62649114560
-
The safety of olanzapine in adolescents with schizophrenia or bipolar i disorder: A pooled analysis of 4 clinical trials
-
Kryzhanovskaya LA, Robertson-Plouch CK, Xu W, Carlson JL, Merida KM, Dittmann RW: The safety of olanzapine in adolescents with schizophrenia or bipolar I disorder: a pooled analysis of 4 clinical trials. J Clin Psychiatry 70:247-58, 2009b.
-
(2009)
J Clin Psychiatry
, vol.70
, pp. 247-258
-
-
Kryzhanovskaya, L.A.1
Robertson-Plouch, C.K.2
Xu Carlson, W.J.L.3
Merida, K.M.4
Dittmann, R.W.5
-
35
-
-
37149041941
-
Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia
-
Kumra S, Oberstar JV, Sikich L, Findling RL, McClellan JM, Vinogradov S, Charles Schulz S: Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia. Schizophr Bull 34:60-71, 2008.
-
(2008)
Schizophr Bull
, vol.34
, pp. 60-71
-
-
Kumra, S.1
Oberstar, J.V.2
Sikich, L.3
Findling, R.L.4
McClellan, J.M.5
Vinogradov, S.6
Charles Schulz, S.7
-
36
-
-
0026586232
-
Clozapine-induced weight gain: Prevalence and clinical relevance
-
Leadbetter R, Shutty M, Pavalonis D, Vieweg V, Higgins P, Downs M: Clozapine-induced weight gain: prevalence and clinical relevance. Am J Psychiatry 149:68-72, 1992.
-
(1992)
Am J Psychiatry
, vol.149
, pp. 68-72
-
-
Leadbetter, R.1
Shutty, M.2
Pavalonis, D.3
Vieweg, V.4
Higgins, P.5
Downs, M.6
-
37
-
-
79953813625
-
Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar i disorder in adolescent patients
-
Maloney AE, Sikich L: Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients. Neuropsychiatr Dis Treat 6:749-66, 2010.
-
(2010)
Neuropsychiatr Dis Treat
, vol.6
, pp. 749-766
-
-
Maloney, A.E.1
Sikich, L.2
-
38
-
-
79551559508
-
Management of schizophrenia in children and adolescents: Focus on pharmacotherapy
-
Masi G, Liboni F: Management of schizophrenia in children and adolescents: focus on pharmacotherapy. Drugs 71:179-208, 2011.
-
(2011)
Drugs
, vol.71
, pp. 179-208
-
-
Masi, G.1
Liboni, F.2
-
39
-
-
84868616853
-
Neural correlates of weight gain with olanzapine
-
Mathews J, Newcomer JW, Mathews JR, Fales CL, Pierce KJ, Akers BK, Marcu I, Barch DM: Neural correlates of weight gain with olanzapine. Arch Gen Psychiatry 69:1226-1237, 2012.
-
(2012)
Arch Gen Psychiatry
, vol.69
, pp. 1226-1237
-
-
Mathews, J.1
Newcomer, J.W.2
Mathews, J.R.3
Fales, C.L.4
Pierce, K.J.5
Akers, B.K.6
Marcu, I.7
Barch, D.M.8
-
40
-
-
0032744616
-
Early-onset psychotic disorders: Course and outcome over a 2-year period
-
McClellan J, McCurry C, Snell J, DuBose A: Early-onset psychotic disorders: Course and outcome over a 2-year period. J Am Acad Child Adolesc Psychiatry 38:1380-1388, 1999.
-
(1999)
J Am Acad Child Adolesc Psychiatry
, vol.38
, pp. 1380-1388
-
-
McClellan, J.1
McCurry, C.2
Snell, J.3
Dubose, A.4
-
41
-
-
0037210111
-
Clozapine-induced weight gain predicts improvement in psychopathology
-
Meltzer HY, Perry E, Jayathilake K: Clozapine-induced weight gain predicts improvement in psychopathology. Schizophr Res 59:19-27, 2002.
-
(2002)
Schizophr Res
, vol.59
, pp. 19-27
-
-
Meltzer, H.Y.1
Perry, E.2
Jayathilake, K.3
-
42
-
-
27744456032
-
The clinical antipsychotic trials of intervention effectiveness (catie) schizophrenia trial: Clinical comparison of subgroups with and without the metabolic syndrome
-
Meyer JM, Nasrallah HA, McEvoy JP, Goff DC, Davis SM, Chakos M, Patel JK, Keefe RS, Stroup TS, Lieberman JA: The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: Clinical comparison of subgroups with and without the metabolic syndrome. Schizophr Res 80:9-18, 2005.
-
(2005)
Schizophr Res
, vol.80
, pp. 9-18
-
-
Meyer, J.M.1
Nasrallah, H.A.2
McEvoy, J.P.3
Goff, D.C.4
Davis, S.M.5
Chakos, M.6
Patel, J.K.7
Keefe, R.S.8
Stroup, T.S.9
Lieberman, J.A.10
-
43
-
-
74549159752
-
Prevalence of high body mass index in US children and adolescents 2007-2008
-
Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM: Prevalence of high body mass index in US children and adolescents, 2007-2008.JAMA 303:242-249, 2010.
-
(2010)
JAMA
, vol.303
, pp. 242-249
-
-
Ogden, C.L.1
Carroll, M.D.2
Curtin, L.R.3
Lamb, M.M.4
Flegal, K.M.5
-
44
-
-
33744907790
-
National trends in the outpatient treatment of children and adolescents with antipsychotic drugs
-
Olfson M, Blanco C, Liu L, Moreno C, Laje G: National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry 63:679-685, 2006.
-
(2006)
Arch Gen Psychiatry
, vol.63
, pp. 679-685
-
-
Olfson, M.1
Blanco, C.2
Liu, L.3
Moreno, C.4
Laje, G.5
-
45
-
-
0019914121
-
The brief psychiatric rating scale for children
-
Overall JE, Pfefferbaum B: The Brief Psychiatric Rating Scale for Children. Psychopharmacol Bull 18:10-16, 1982.
-
(1982)
Psychopharmacol Bull
, vol.18
, pp. 10-16
-
-
Overall, J.E.1
Pfefferbaum, B.2
-
46
-
-
0036514352
-
Weight gain associated with olanzapine and risperidone in adolescent patients: A comparative prospective study
-
Ratzoni G, Gothelf D, Brand-Gothelf A, Reidman J, Kikinzon L, Gal G, Phillip M, Apter A, Weizman R: Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study. J Am Acad Child Adolesc Psychiatry 41:337-343, 2002.
-
(2002)
J Am Acad Child Adolesc Psychiatry
, vol.41
, pp. 337-343
-
-
Ratzoni, G.1
Gothelf, D.2
Brand-Gothelf, A.3
Reidman, J.4
Kikinzon, L.5
Gal, G.6
Phillip, M.7
Apter, A.8
Weizman, R.9
-
47
-
-
0034806737
-
Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine (2C) receptor
-
Rauser L, Savage JE, Meltzer HY, Roth BL: Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine (2C) receptor. J Pharmacol Exp Ther 299:83-89, 2001.
-
(2001)
J Pharmacol Exp Ther
, vol.299
, pp. 83-89
-
-
Rauser, L.1
Savage, J.E.2
Meltzer, H.Y.3
Roth, B.L.4
-
48
-
-
82555177312
-
Atypical antipsychotic-induced weight gain: Insights into mechanisms of action
-
Roerig JL, Steffen KJ, Mitchell JE: Atypical antipsychotic-induced weight gain: Insights into mechanisms of action. CNS Drugs 25:1035-1059, 2011.
-
(2011)
CNS Drugs
, vol.25
, pp. 1035-1059
-
-
Roerig, J.L.1
Steffen, K.J.2
Mitchell, J.E.3
-
49
-
-
33750617060
-
High rates of comorbidity are found in childhood-onset schizophrenia
-
Ross RG, Heinlein S, Tregellas H: High rates of comorbidity are found in childhood-onset schizophrenia. Schizophr Res 88:90-95, 2006.
-
(2006)
Schizophr Res
, vol.88
, pp. 90-95
-
-
Ross, R.G.1
Heinlein, S.2
Tregellas, H.3
-
50
-
-
0142025523
-
A 1-year open-label trial of olanzapine in school-age children with schizophrenia
-
Ross RG, Novins D, Farley GK, Adler LE: A 1-year open-label trial of olanzapine in school-age children with schizophrenia. J Child Adolesc Psychopharmacol 13:301-309, 2003.
-
(2003)
J Child Adolesc Psychopharmacol
, vol.13
, pp. 301-309
-
-
Ross, R.G.1
Novins, D.2
Farley, G.K.3
Adler, L.E.4
-
51
-
-
55749083565
-
Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: Findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study
-
Sikich L, Frazier JA, McClellan J, Findling RL, Vitiello B, Ritz L, Ambler D, Puglia M, Maloney AE, Michael E, De Jong S, Slifka K, Noyes N, Hlastala S, Pierson L, McNamara NK, Delporto-Bedoya D, Anderson R, Hamer RM, Lieberman JA: Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: Findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study. Am J Psychiatry 165:1420-1431, 2008.
-
(2008)
Am J Psychiatry
, vol.165
, pp. 1420-1431
-
-
Sikich, L.1
Frazier, J.A.2
McClellan, J.3
Findling, R.L.4
Vitiello, B.5
Ritz, L.6
Ambler, D.7
Puglia, M.8
Maloney, A.E.9
Michael, E.10
De Jong, S.11
Slifka, K.12
Noyes, N.13
Hlastala, S.14
Pierson, L.15
McNamara, N.K.16
Delporto-Bedoya, D.17
Anderson, R.18
Hamer, R.M.19
Lieberman, J.A.20
more..
-
52
-
-
81855204965
-
A randomized, Double-blind study of paliperidone extended-release in treatment of acute schizophrenia in adolescents
-
Singh J, Robb A, Vijapurkar U, Nuamah I, Hough D: A randomized, double-blind study of paliperidone extended-release in treatment of acute schizophrenia in adolescents. Biol Psychiatry 70:1179-1187, 2011.
-
(2011)
Biol Psychiatry
, vol.70
, pp. 1179-1187
-
-
Singh, J.1
Robb, A.2
Vijapurkar, U.3
Nuamah, I.4
Hough, D.5
-
53
-
-
0014876487
-
Weight as a correlate of clinical response to psychotropic drugs
-
Singh MM, De Dios LV, Klein NS: Weight as a correlate of clinical response to psychotropic drugs. Psychosomatics 11:562-570, 1970.
-
(1970)
Psychosomatics
, vol.11
, pp. 562-570
-
-
Singh, M.M.1
De Dios, L.V.2
Klein, N.S.3
-
54
-
-
80052490081
-
The schizophrenia trials network: A randomized trial examining the effectiveness of switching from olanzapine, Quetiapine, or risperidone to aripiprazole to reduce metabolic risk: Comparison of antipsychotics for metabolic problems (camp)
-
Stroup TS, McEvoy JP, Ring KD, Hamer RH, Lavange LM, Swartz MS, Rosenheck RA, Perkins DO, Nussbaum AM, Lieberman JA, the Schizophrenia Trials Network: A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: Comparison of Antipsychotics for Metabolic Problems (CAMP). Am J Psychiatry 168:947-956, 2011.
-
(2011)
Am J Psychiatry
, vol.168
, pp. 947-956
-
-
Stroup, T.S.1
McEvoy, J.P.2
Ring, K.D.3
Hamer, R.H.4
Lavange, L.M.5
Swartz, M.S.6
Rosenheck, R.A.7
Perkins, D.O.8
Nussbaum, A.M.9
Lieberman, J.A.10
-
55
-
-
0034782477
-
Prevalence of obesity in adolescent and young adult patients with and without schizophrenia and in relationship to antipsychotic medication
-
Theisen FM, Linden A, Geller F, Schafer H, Martin M, Remschmidt H, Hebebrand J: Prevalence of obesity in adolescent and young adult patients with and without schizophrenia and in relationship to antipsychotic medication. J Psychiatr Res 35:339-345, 2001.
-
(2001)
J Psychiatr Res
, vol.35
, pp. 339-345
-
-
Theisen, F.M.1
Linden, A.2
Geller, F.3
Schafer, H.4
Martin, M.5
Remschmidt, H.6
Hebebrand, J.7
-
56
-
-
33745395221
-
Prevalence and clinical correlates of medical comorbidities in patients with bipolar i disorder: Analysis of acute phase data from a randomized controlled trial
-
Thompson WK, Kupfer DJ, Fagiolini A, Scott JA, Frank E: Prevalence and clinical correlates of medical comorbidities in patients with bipolar I disorder: Analysis of acute phase data from a randomized controlled trial. J Clin Psychiatry 67: 783-788, 2006.
-
(2006)
J Clin Psychiatry
, vol.67
, pp. 783-788
-
-
Thompson, W.K.1
Kupfer, D.J.2
Fagiolini, A.3
Scott, J.A.4
Frank, E.5
-
58
-
-
0028051552
-
Clinical features and outcome of child and adolescent schizophrenia
-
Werry JS, McClellan JM, Andrews LK, Ham M: Clinical features and outcome of child and adolescent schizophrenia. Schizophr Bull 20:619-630, 1994.
-
(1994)
Schizophr Bull
, vol.20
, pp. 619-630
-
-
Werry, J.S.1
McClellan, J.M.2
Andrews, L.K.3
Ham, M.4
-
59
-
-
0022656140
-
The Overt Aggression Scale for the objective rating of verbal and physical aggression
-
Yudofsky SC, Silver JM, Jackson W, Endicott J, Williams D: The Overt Aggression Scale for the objective rating of verbal and physical aggression. Am J Psychiatry 143:35-3n9, 1986.
-
(1986)
Am J Psychiatry
, vol.143
, pp. 35-39
-
-
Yudofsky, S.C.1
Silver, J.M.2
Jackson, W.3
Endicott, J.4
Williams, D.5
|